Whitepapers
![](https://www.wcgclinical.com/wp-content/uploads/2024/07/Vol-5-Issue-5-irRECIST-and-Immuno-Oncology-in-Clinical-Trials.jpg)
irRECIST and Immuno-Oncology in Clinical Trials
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2024/06/Vol-5-Issue-4-Temporal-Lobe-Epilepsy-and-Volumetric-MRI-in-Clinical-Trials.jpg)
Temporal Lobe Epilepsy and Volumetric MRI in Clinical Trials
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2024/06/Vol-5-Issue-3-Functional-Imaging-of-the-Dopamine-Pathway.jpg)
Functional Imaging of the Dopamine Pathway
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2024/06/Vol-5-Issue-2-Advances-in-Imaging-of-Non-Small-Cell-Lung-Cancer.jpg)
Advances in Imaging of Non-Small Cell Lung Cancer (NSCLC)
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-15.jpg)
Breaking Barriers: Reasons to Expand Site Cancer Clinical Trial Portfolios
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2022/08/imaging-review-computer.jpg)
Clinical Trial Safety
Understanding Endpoint and Safety Review
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2024/06/Intrinsic-Imaging-Volume-5-Issue-1-Immunotherapy-and-Imaging-of-Metastatic-Pancreatic-Adenocarcinoma-scaled.jpg)
Immunotherapy and Imaging of Metastatic Pancreatic Adenocarcinoma
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2024/01/shutterstock_1463202665-scaled.jpg)
The Basics Aren’t So Basic: Successful Participant Recruitment Requires Dedicated Time, Better Relationships, and Adequate Site Support
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2023/12/TNIcover-01.png)
Series: WCG Trends & Insights
Clinical Trial Trends & Insights 2024
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2023/12/imaging11.jpg)
Clinical Endpoints